LeapScholar

Which country between the UK and New Zealand has better employability and return on investment for my master's in pharmacology?

23 Jun 2026 · Answered by Swastika Ghosh · 1 min read
Swastika Ghosh
Swastika Ghosh Verified
Leap Scholar's Counsellor
View Profile →

For a Master's in Pharmacology, both the UK and New Zealand offer strong employability and ROI, but with different advantages.

- UK: Shorter programs (12 months), higher total cost (₹30 - 50 lakh typical), and access to a large job market. The post-study work visa (Graduate Route) allows you to stay for 2 years after graduation, but moving to long-term work status requires meeting a high salary threshold.

- New Zealand: Programs are longer (18 - 24 months), with a typical total cost of ₹28 - 42 lakh. The post-study work visa is 3 years and offers a clearer pathway to permanent residency, especially for healthcare professionals. The job market is less saturated, and demand for pharmacy graduates is high.

If you want a shorter program and immediate access to a wide range of jobs, the UK is a strong choice. If your priority is long-term settlement and a smoother residency pathway, New Zealand may offer better ROI. Both are viable for your profile and January 2027 intake. For personalized guidance, connect with your LeapScholar counsellor.

Still have doubts?

Speak to a LeapScholar expert — free, no obligations.

4.7/5 Google 🎓 25K+ admits
Book Free Counselling Session

More Post-study work questions

More New Zealand questions

Book a free counselling call Book Now